Novo A/S (investor - Corporate Investor)
Novo A/S is a private limited liability company fully owned by the Novo Nordisk Foundation.
Besides being the major shareholder in the Novo Group companies, Novo A/S provides seed (Novo Seeds) and venture capital (Novo Ventures) to development stage companies and takes significant ownership positions in well-established companies, within life science, as well as manages a broad portfolio of financial assets.
Showing 3 of 6 tracked Nordic investments in:
|Name||Date||Round value||Total raised|
|Gesynta Pharma||Feb 2018||2.73M||9.50M|
* The round values and totals raised are in USD.
** Click on the company for its details and on the round amount for the investment details.